Cargando…

Capecitabine for primary breast cancer

Detalles Bibliográficos
Autores principales: Toi, Masakazu, Masuda, Norikazu, Lee, Soo-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762279/
https://www.ncbi.nlm.nih.gov/pubmed/29340011
http://dx.doi.org/10.18632/oncotarget.22990
_version_ 1783291650956591104
author Toi, Masakazu
Masuda, Norikazu
Lee, Soo-Jung
author_facet Toi, Masakazu
Masuda, Norikazu
Lee, Soo-Jung
author_sort Toi, Masakazu
collection PubMed
description
format Online
Article
Text
id pubmed-5762279
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57622792018-01-16 Capecitabine for primary breast cancer Toi, Masakazu Masuda, Norikazu Lee, Soo-Jung Oncotarget Editorial Impact Journals LLC 2017-12-06 /pmc/articles/PMC5762279/ /pubmed/29340011 http://dx.doi.org/10.18632/oncotarget.22990 Text en Copyright: © 2017 Toi et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Toi, Masakazu
Masuda, Norikazu
Lee, Soo-Jung
Capecitabine for primary breast cancer
title Capecitabine for primary breast cancer
title_full Capecitabine for primary breast cancer
title_fullStr Capecitabine for primary breast cancer
title_full_unstemmed Capecitabine for primary breast cancer
title_short Capecitabine for primary breast cancer
title_sort capecitabine for primary breast cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762279/
https://www.ncbi.nlm.nih.gov/pubmed/29340011
http://dx.doi.org/10.18632/oncotarget.22990
work_keys_str_mv AT toimasakazu capecitabineforprimarybreastcancer
AT masudanorikazu capecitabineforprimarybreastcancer
AT leesoojung capecitabineforprimarybreastcancer